Can You Be on Hospice and Still Have All BP and Diabetes Medications Ordered?
No, you should not continue all blood pressure and diabetes medications when on hospice—strict control is not necessary, and many medications should be simplified, reduced, or discontinued based on the patient's clinical status and goals of comfort. 1
Framework for Medication Management in Hospice
The most recent American Diabetes Association guidelines (2025) provide clear direction: when palliative care is needed, strict glucose and blood pressure management are not necessary, and simplification of medication plans should be considered 1. This represents a fundamental shift from disease-modifying treatment to symptom-focused care prioritizing quality of life and dignity 1.
Three Clinical Categories Guide Decision-Making
1. Stable Hospice Patient:
- Continue the previous medication regimen with modifications
- Primary focus: prevent hypoglycemia (more dangerous than mild hyperglycemia)
- Secondary focus: prevent severe hyperglycemia causing dehydration
- Allow glucose values in the 200-300 mg/dL range to avoid hypoglycemia risk 2
- No role for A1C monitoring 3
2. Patient with Organ Failure:
- Preventing hypoglycemia becomes paramount
- For Type 2 diabetes: reduce doses of agents causing hypoglycemia (sulfonylureas, insulin)
- For Type 1 diabetes: reduce but do not stop insulin as oral intake decreases
- Allow glucose values in the upper target range 1
- Prevent and treat dehydration aggressively
3. Actively Dying Patient:
- For Type 2 diabetes: discontinuation of all diabetes medications is reasonable as oral intake ceases 3
- For Type 1 diabetes: consider minimal basal insulin only to prevent acute hyperglycemic complications 1
Blood Pressure Medications
Strict blood pressure control may not be necessary, and withdrawal of therapy may be appropriate 4, 3. The 2024 American Heart Association guidelines on palliative pharmacotherapy support deprescribing when medications no longer align with comfort-focused goals 5. Avoiding severe hypertension remains reasonable, but tight control that risks hypotension, falls, or adverse effects should be abandoned.
Specific Deprescribing Considerations:
Diabetes Medications to Consider Stopping:
- Statins (shown to improve quality of life when withdrawn in palliative care) 3
- Medications causing GI symptoms (nausea, weight loss) 4
- Agents with high hypoglycemia risk (sulfonylureas, rapid-acting insulin)
- Medications requiring frequent monitoring
What May Continue:
- Simple oral agents if preventing symptomatic hyperglycemia
- Basal insulin in simplified regimens (without rapid-acting insulin) 1
- Medications preventing distressing symptoms (severe hyperglycemia with polyuria/dehydration)
Critical Clinical Pitfalls
Common Error #1: Continuing aggressive glycemic control out of habit or discomfort discussing medication withdrawal. Research shows 29.8-30.5% of hospice patients inappropriately continue limited-benefit medications 6.
Common Error #2: Fear that mild hyperglycemia causes symptoms. Evidence shows glucose levels of 200-300 mg/dL are well-tolerated and safer than risking hypoglycemia 2.
Common Error #3: Failing to have explicit conversations with patients and families about medication goals. The decision process must involve the patient, family, and caregivers to create a care plan aligned with comfort goals 3.
Evidence Quality and Nuances
The strongest evidence comes from the 2025 ADA Standards of Care 1, which supersedes earlier versions 7, 4, 3. These guidelines consistently emphasize across multiple years that overall comfort, prevention of distressing symptoms, and preservation of quality of life and dignity are primary goals at end of life 4, 1.
Research data reveals concerning patterns: statins have median discontinuation times of 93 days in hospice, and diabetes medications 197 days—far too long for end-of-life care 8. Anti-dementia medications are continued in 29.3% of hospice patients despite limited benefit 6.
The 2024 AHA statement on palliative pharmacotherapy reinforces that deprescribing is essential when polypharmacy increases adverse drug reactions without offsetting benefits 5. This applies directly to preventive medications like antihypertensives and statins in hospice patients.
Practical Implementation
At Hospice Enrollment:
- Initiate conversations about medication goals immediately 3
- Reduce frequency of glucose monitoring (or consider CGM if less burdensome) 1
- Simplify insulin regimens: basal only, no rapid-acting 4
- Discontinue statins and other preventive medications 3
Ongoing Management:
- Target glucose prevention of hypoglycemia (<70 mg/dL) and severe hyperglycemia (>300 mg/dL sustained) 1
- Blood pressure: avoid severe hypertension but do not pursue tight control
- Taper and discontinue medications as symptoms progress 4
The evidence unequivocally supports medication simplification in hospice, with individualization based on the three clinical categories above rather than continuing all prior medications.